查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1235973

人绒毛膜促性腺激素全球市场规模调查和预测，按技术/治疗领域/最终用户，区域分析，2022-2029

Global Human Chorionic Gonadotropin Market Size study & Forecast, by Technology, Therapeutic Area, and End User and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球人绒毛膜促性腺激素 (hCG) 市场价值约为 9.2 亿美元，在 2022-2029 年的预测期内健康增长率超过 7.6%。预计增长.

在怀孕期间，胎盘会分泌一种称为人绒毛膜促性腺激素 (hCG) 的激素。 这种激素向身体发出停止月经并增厚子宫内膜以支持发育中的胚胎的信号。 受精后，HCG 水平上升，并在怀孕第 10 週后继续上升。 在女性生育治疗中，hCG 用于维持黄体期，促进卵泡最终成熟，并触发排卵。 它还用于在雄性激素缺乏和男性性腺机能减退等情况下增加间质细胞产生的睪酮。 老年人男性性腺功能减退症发病率的增加和 hCG 在医疗保健从业者中的日益普及是推动市场增长的主要因素。

多年来，男性性腺功能减退症的流行促进了全球人绒毛膜促性腺激素 (hCG) 市场的增长。 例如，波士顿大学医学院 (BUMC) 估计，美国约有 4 至 5 百万男性患有性腺功能减退症。 此外，新兴经济体医疗保健的发展和不同剂量重组 hCG 可用性的增加预计将在预测期内为市场提供有利可图的增长机会。 然而，对 FDA 发布的 hCG 治疗副作用的警告和警告的担忧阻碍了整个 2022-2029 年预测期内的市场增长。 例如，2020 年 7 月，美国食品药品监督管理局 (FDA) 发布了一项建议，要求消费者避免使用 HCG 减肥产品。

全球人绒毛膜促性腺激素 (hCG) 市场研究中考虑的主要区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于主要市场参与者的主导地位以及男性和女性与不育相关问题的发生率上升，北美在收入方面占据了市场主导地位。 另一方面，由于老年人口增加、医疗设施扩张等因素，预计亚太地区在预测期内将以最高复合年增长率增长。

近期市场趋势

  • 2020 年 7 月，FDA 从可销售产品中移除了减肥成分 hCG。 FDA 继续表示，所有宣传使用 hCG 作为减肥成分的非处方药和饮食都是虚假的、非法的，并且没有证据支持他们的说法。 FDA 还表示，产品销售商建议在使用补充剂时每天摄入 500 卡路里的热量，这可能是致命的。

全球人绒毛膜促性腺激素 (hCG) 市场报告范围

  • 历史数据：2019-2020-2021
  • 估算基准年：2021 年
  • 预测期：2022-2029
  • 报告范围：收入预测、公司排名、竞争格局、增长因素、趋势
  • 按地区划分：北美、欧洲、亚太地区、拉丁美洲、世界其他地区
  • 定制范围：免费报告定制（最多 8 个工作小时）。 按国家、地区和部门划分的范围的添加和更改。

本研究的目的是弄清近年来各个领域和国家的市场规模，并对未来几年的市场规模进行预测。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还结合了利益相关者投资的潜在微观市场机会，以及主要参与者的竞争格局等详细分析。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 2019-2029 年按地区分列的人绒毛膜促性腺激素 (hCG) 市场
    • 人绒毛膜促性腺激素 (hCG) 市场，按技术划分，2019-2029 年
    • 人绒毛膜促性腺激素 (hCG) 市场，按治疗领域划分，2019-2029 年
    • 人绒毛膜促性腺激素 (hCG) 市场：按最终用户分类，2019-2029 年
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章人绒毛膜促性腺激素 (hCG) 全球市场定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第 3 章人绒毛膜促性腺激素 (hCG) 的全球市场动态

  • 人绒毛膜促性腺激素 (hCG) 市场影响分析 (2019-2029)
    • 市场驱动力
      • 老年人男性性腺功能减退症的发病率上升
      • hCG 在医疗保健专业人士中越来越受欢迎
    • 市场挑战
      • 对 FDA 公布的 hCG 治疗副作用的注意事项和警告的担忧
    • 市场进入潜力
      • 新兴经济体的医疗保健基础设施增长
      • 不同剂量的重组 hCG 的可用性更高

第 4 章全球人绒毛膜促性腺激素 (hCG) 市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 最佳投资机会
  • 关键成功策略
  • 业内人士的前景
  • 分析师的建议和结论

第 5 章风险评估 COVID-19 影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章人绒毛膜促性腺激素 (hCG) 的全球市场：按技术分类

  • 市场概况
  • 人绒毛膜促性腺激素 (hCG) 全球市场：按技术、性能分类 - 潜力分析
  • 人绒毛膜促性腺激素 (hCG) 全球市场按技术估算和预测 2019-2029
  • 人绒毛膜促性腺激素 (hCG) 市场，细分分析
    • 提取天然成分
    • 重组技术

第 7 章。全球人绒毛膜促性腺激素 (hCG) 市场：按治疗领域分类

  • 市场概况
  • 全球人绒毛膜促性腺激素 (hCG) 市场：按治疗领域划分的性能潜力分析
  • 2019-2029 年按治疗领域分列的人绒毛膜促性腺激素 (hCG) 全球市场估计和预测
  • 人绒毛膜促性腺激素 (hCG) 市场，细分分析
    • 女性不孕症治疗
    • 贫血治疗
    • 男性性腺功能减退症

第 8 章人绒毛膜促性腺激素 (hCG) 的全球市场：最终用户

  • 市场概况
  • 全球人绒毛膜促性腺激素 (hCG) 市场：按最终用户分类，性能潜力分析
  • 2019-2029 年人绒毛膜促性腺激素 (hCG) 全球市场估计和预测（按最终用户）
  • 人绒毛膜促性腺激素 (hCG) 市场，细分分析
    • 孕妇诊所
    • 关于研究机构

第 9 章人绒毛膜促性腺激素 (hCG) 的全球市场：区域分析

  • 人绒毛膜促性腺激素 (hCG) 市场，区域市场概况
  • 北美
    • 美国
      • 按技术估算和预测，2019-2029 年
      • 2019-2029 年各治疗领域的估计和预测
      • 2019-2029 年最终用户的估计和预测
    • 加拿大
  • 欧洲人绒毛膜促性腺激素 (hCG) 市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太地区人绒毛膜促性腺激素 (hCG) 市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲人绒毛膜促性腺激素 (hCG) 市场概况
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 世界其他地方

第 10 章衝突信息

  • 顶级市场策略
  • 公司简介
    • 百时美施贵宝有限公司
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 产品概览
      • 近期趋势
    • Ferring Pharmaceuticals Inc
    • Merck & Co., Inc
    • Fresenius Kabi AG
    • Cigna
    • Sun Pharmaceutical Industries Ltd
    • Lee BioSolutions Inc
    • Sanzyme Biologics Private Ltd.
    • Scripps Laboratories Inc.
    • LUPIN Limited

第 11 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

Global Human Chorionic Gonadotropin (hCG) Market is valued at approximately USD 0.92 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.6 % over the forecast period 2022-2029. During pregnancy, the placenta secretes a hormone called human chorionic gonadotropin (hCG). It signals the body to cease menstruating and thickens the uterine lining to support a developing embryo. After fertilisation, HCG levels increase and stay elevated for another 10 weeks or more of pregnancy. While treating infertility in women, hCG is used to maintain the luteal phase, promote final follicular maturation, and cause ovulation. It is used to increase testosterone production in males by the Leydig cells in conditions such as hormone insufficiency and male hypogonadism. The increasing incidence of male hypogonadism among the geriatric population and the growing popularity of hCG among healthcare professionals are key factors driving the market growth.

Over the years the prevalence of hypogonadism among male is contributing towards the growth of the Global Human Chorionic Gonadotropin (hCG) Market. For instance - as per Boston University Medical Campus (BUMC) estimates - Hypogonadism affects an estimated 4 to 5 million men in the United States. Also, growing healthcare infrastructure in developing economies as well as the rising availability of recombinant hCGs in different dose strengths would create lucrative growth opportunities for the market over the projected period. However, concern over cautions and warnings issued by the FDA over the probable side effects of hCG therapy hinders the market growth throughout the forecast period of 2022-2029. For instance, in July 2020, The Food and Drug Administration (FDA) announced an advisory for consumers to avoid HCG weight-loss products.

The key regions considered for the Global Human Chorionic Gonadotropin (hCG) Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of leading market players as well as the rise in the incidence of infertility-related problems both in males and females. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing expansion of healthcare facilities in the region.

Major market players included in this report are:

  • Bristol Myers Squibb Company
  • Ferring Pharmaceuticals Inc
  • Merck & Co., Inc
  • Fresenius Kabi AG
  • Cigna
  • Sun Pharmaceutical Industries Ltd
  • Lee BioSolutions Inc
  • Sanzyme Biologics Private Ltd.
  • Scripps Laboratories Inc.
  • LUPIN Limited

Recent Developments in the Market:

  • In july 2020, The FDA eliminated hCG, a weight-loss ingredient, from marketable products. The FDA continued by stating that all over-the-counter medications and diets that advertise the use of hCG as a weight-loss ingredient are false and illegal and that there is also no evidence to support the claims made. FDA continued by stating that the restriction of 500 calories per day while using the supplement has been introduced by the product sellers, which could be lethal.

Global Human Chorionic Gonadotropin (hCG) Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Technology, Therapeutic Area, End User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology

  • Natural Source Extraction
  • Recombinant Technology

By Therapeutic Area

  • Female Infertility Treatment
  • Male Hypogonadism
  • Oligospermic Treatment

By End User

  • Fertility Clinics
  • Research Institutes

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Human Chorionic Gonadotropin (hCG) Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Human Chorionic Gonadotropin (hCG) Market, by Technology, 2019-2029 (USD Billion)
    • 1.2.3. Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2019-2029 (USD Billion)
    • 1.2.4. Human Chorionic Gonadotropin (hCG) Market, by End User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Human Chorionic Gonadotropin (hCG) Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Human Chorionic Gonadotropin (hCG) Market Dynamics

  • 3.1. Human Chorionic Gonadotropin (hCG) Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of male hypogonadism among the geriatric population
      • 3.1.1.2. Growing popularity of hCG among healthcare professionals
    • 3.1.2. Market Challenges
      • 3.1.2.1. Concern over cautions and warnings issued by the FDA pertaining to the side effects of hCG therapy.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing healthcare infrastructure in developing economies
      • 3.1.3.2. Rising availability of recombinant hCGs in different dose strengths

Chapter 4. Global Human Chorionic Gonadotropin (hCG) Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Human Chorionic Gonadotropin (hCG) Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Human Chorionic Gonadotropin (hCG) Market by Technology, Performance - Potential Analysis
  • 6.3. Global Human Chorionic Gonadotropin (hCG) Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
  • 6.4. Human Chorionic Gonadotropin (hCG) Market, Sub Segment Analysis
    • 6.4.1. Natural Source Extraction
    • 6.4.2. Recombinant Technology

Chapter 7. Global Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area

  • 7.1. Market Snapshot
  • 7.2. Global Human Chorionic Gonadotropin (hCG) Market by Therapeutic Area, Performance - Potential Analysis
  • 7.3. Global Human Chorionic Gonadotropin (hCG) Market Estimates & Forecasts by Therapeutic Area 2019-2029 (USD Billion)
  • 7.4. Human Chorionic Gonadotropin (hCG) Market, Sub Segment Analysis
    • 7.4.1. Female Infertility Treatment
    • 7.4.2. Oligospermic treatment
    • 7.4.3. Male hypogonadism

Chapter 8. Global Human Chorionic Gonadotropin (hCG) Market, by End User

  • 8.1. Market Snapshot
  • 8.2. Global Human Chorionic Gonadotropin (hCG) Market by End User, Performance - Potential Analysis
  • 8.3. Global Human Chorionic Gonadotropin (hCG) Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
  • 8.4. Human Chorionic Gonadotropin (hCG) Market, Sub Segment Analysis
    • 8.4.1. Fertility Clinics
    • 8.4.2. Research Institutions

Chapter 9. Global Human Chorionic Gonadotropin (hCG) Market, Regional Analysis

  • 9.1. Human Chorionic Gonadotropin (hCG) Market, Regional Market Snapshot
  • 9.2. North America Human Chorionic Gonadotropin (hCG) Market
    • 9.2.1. U.S. Human Chorionic Gonadotropin (hCG) Market
      • 9.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Therapeutic Area breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Human Chorionic Gonadotropin (hCG) Market
  • 9.3. Europe Human Chorionic Gonadotropin (hCG) Market Snapshot
    • 9.3.1. U.K. Human Chorionic Gonadotropin (hCG) Market
    • 9.3.2. Germany Human Chorionic Gonadotropin (hCG) Market
    • 9.3.3. France Human Chorionic Gonadotropin (hCG) Market
    • 9.3.4. Spain Human Chorionic Gonadotropin (hCG) Market
    • 9.3.5. Italy Human Chorionic Gonadotropin (hCG) Market
    • 9.3.6. Rest of Europe Human Chorionic Gonadotropin (hCG) Market
  • 9.4. Asia-Pacific Human Chorionic Gonadotropin (hCG) Market Snapshot
    • 9.4.1. China Human Chorionic Gonadotropin (hCG) Market
    • 9.4.2. India Human Chorionic Gonadotropin (hCG) Market
    • 9.4.3. Japan Human Chorionic Gonadotropin (hCG) Market
    • 9.4.4. Australia Human Chorionic Gonadotropin (hCG) Market
    • 9.4.5. South Korea Human Chorionic Gonadotropin (hCG) Market
    • 9.4.6. Rest of Asia Pacific Human Chorionic Gonadotropin (hCG) Market
  • 9.5. Latin America Human Chorionic Gonadotropin (hCG) Market Snapshot
    • 9.5.1. Brazil Human Chorionic Gonadotropin (hCG) Market
    • 9.5.2. Mexico Human Chorionic Gonadotropin (hCG) Market
    • 9.5.3. Rest of Latin America Human Chorionic Gonadotropin (hCG) Market
  • 9.6. Rest of The World Human Chorionic Gonadotropin (hCG) Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Bristol Mayer Squibb Limited
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Ferring Pharmaceuticals Inc
    • 10.2.3. Merck & Co., Inc
    • 10.2.4. Fresenius Kabi AG
    • 10.2.5. Cigna
    • 10.2.6. Sun Pharmaceutical Industries Ltd
    • 10.2.7. Lee BioSolutions Inc
    • 10.2.8. Sanzyme Biologics Private Ltd.
    • 10.2.9. Scripps Laboratories Inc.
    • 10.2.10. LUPIN Limited

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Human Chorionic Gonadotropin (hCG) Market, report scope
  • TABLE 2. Global Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by Technology 2019-2029 (USD Billion)
  • TABLE 4. Global Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by Therapeutic Area 2019-2029 (USD Billion)
  • TABLE 5. Global Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by End User 2019-2029 (USD Billion)
  • TABLE 6. Global Human Chorionic Gonadotropin (hCG) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Human Chorionic Gonadotropin (hCG) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Human Chorionic Gonadotropin (hCG) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Human Chorionic Gonadotropin (hCG) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Human Chorionic Gonadotropin (hCG) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Human Chorionic Gonadotropin (hCG) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Human Chorionic Gonadotropin (hCG) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Human Chorionic Gonadotropin (hCG) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Human Chorionic Gonadotropin (hCG) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Human Chorionic Gonadotropin (hCG) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Human Chorionic Gonadotropin (hCG) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Human Chorionic Gonadotropin (hCG) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Human Chorionic Gonadotropin (hCG) Market
  • TABLE 71. List of primary sources, used in the study of global Human Chorionic Gonadotropin (hCG) Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Human Chorionic Gonadotropin (hCG) Market, research methodology
  • FIG 2. Global Human Chorionic Gonadotropin (hCG) Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Human Chorionic Gonadotropin (hCG) Market, key trends 2021
  • FIG 5. Global Human Chorionic Gonadotropin (hCG) Market, growth prospects 2022-2029
  • FIG 6. Global Human Chorionic Gonadotropin (hCG) Market, porters 5 force model
  • FIG 7. Global Human Chorionic Gonadotropin (hCG) Market, pest analysis
  • FIG 8. Global Human Chorionic Gonadotropin (hCG) Market, value chain analysis
  • FIG 9. Global Human Chorionic Gonadotropin (hCG) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Human Chorionic Gonadotropin (hCG) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Human Chorionic Gonadotropin (hCG) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Human Chorionic Gonadotropin (hCG) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Human Chorionic Gonadotropin (hCG) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Human Chorionic Gonadotropin (hCG) Market, regional snapshot 2019 & 2029
  • FIG 15. North America Human Chorionic Gonadotropin (hCG) Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Human Chorionic Gonadotropin (hCG) Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Human Chorionic Gonadotropin (hCG) Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Human Chorionic Gonadotropin (hCG) Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Human Chorionic Gonadotropin (hCG) Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable